Financhill
Sell
19

EE Quote, Financials, Valuation and Earnings

Last price:
$29.72
Seasonality move :
-13.35%
Day range:
$28.61 - $30.28
52-week range:
$13.38 - $32.25
Dividend yield:
0.45%
P/E ratio:
30.07x
P/S ratio:
1.69x
P/B ratio:
1.44x
Volume:
249.7K
Avg. volume:
275.5K
1-year change:
89.02%
Market cap:
$722.3M
Revenue:
$1.2B
EPS (TTM):
$0.99
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $544.4M $430.8M $888.6M $2.5B $1.2B
Revenue Growth (YoY) -- -20.86% 106.24% 178.31% -53.14%
 
Cost of Revenues $334.9M $254.6M $688.1M $2.2B $860.9M
Gross Profit $209.5M $176.2M $200.4M $259.7M $298.1M
Gross Profit Margin 38.48% 40.9% 22.55% 10.5% 25.72%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $35.5M $42.9M $47.1M $66.1M $87.5M
Other Inc / (Exp) -$10.1M $3M -$10.1M -$25.7M $16.5M
Operating Expenses $35.5M $42.9M $47.1M $66.1M $87.5M
Operating Income $174M $133.3M $153.3M $193.6M $210.6M
 
Net Interest Expenses $101.9M $89.4M $80.8M $59.5M $67M
EBT. Incl. Unusual Items $62M $46.8M $62.4M $108.3M $160.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $13.7M $13.9M $21.2M $28.3M $33.2M
Net Income to Company $48.3M $32.9M $41.2M $80M $126.8M
 
Minority Interest in Earnings $6.6M $5.9M -$71K -$53.7M -$96.4M
Net Income to Common Excl Extra Items $54.8M $38.8M $41.1M $26.3M $30.4M
 
Basic EPS (Cont. Ops) $2.25 -- -- $0.51 $1.16
Diluted EPS (Cont. Ops) $2.25 -- -- $0.51 $1.11
Weighted Average Basic Share $24.4M $23.9M $24.4M $26.3M $26.3M
Weighted Average Diluted Share $24.4M $23.9M $24.4M $26.3M $108.3M
 
EBITDA $266.5M $252.8M $271.6M $296.9M $356.1M
EBIT $163.8M $136.3M $143.2M $167.9M $227.1M
 
Revenue (Reported) $544.4M $430.8M $888.6M $2.5B $1.2B
Operating Income (Reported) $174M $133.3M $153.3M $193.6M $210.6M
Operating Income (Adjusted) $163.8M $136.3M $143.2M $167.9M $227.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- $192.1M $803.3M $275.5M $193.4M
Revenue Growth (YoY) -- -- 318.06% -65.71% -29.79%
 
Cost of Revenues -- $149.4M $733.2M $188.5M $109.9M
Gross Profit -- $42.7M $70M $87M $83.6M
Gross Profit Margin -- 22.25% 8.72% 31.59% 43.2%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- $11.5M $18.8M $19.5M $23.8M
Other Inc / (Exp) -- -$4.6M -$63K $4.7M $7.1M
Operating Expenses -- $11.5M $18.8M $19.5M $23.8M
Operating Income -- $31.2M $51.3M $67.5M $59.7M
 
Net Interest Expenses -- $20M $13.7M $17.5M $15.1M
EBT. Incl. Unusual Items -- $6.6M $37.5M $54.7M $51.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $5.2M $233K $8.2M $6.2M
Net Income to Company -- $1.4M $37.3M $46.5M $45.5M
 
Minority Interest in Earnings -- $521K -$28.4M -$32.6M -$36.6M
Net Income to Common Excl Extra Items -- $1.9M $8.8M $13.9M $9M
 
Basic EPS (Cont. Ops) -- -- $0.34 $0.53 $0.36
Diluted EPS (Cont. Ops) -- -- $0.34 $0.40 $0.35
Weighted Average Basic Share -- $22.3M $26.3M $26.3M $25M
Weighted Average Diluted Share -- $22.3M $26.3M $108.3M $25.5M
 
EBITDA -- $58.4M $83.8M $107.7M $90.3M
EBIT -- $26.6M $51.2M $72.2M $66.8M
 
Revenue (Reported) -- $192.1M $803.3M $275.5M $193.4M
Operating Income (Reported) -- $31.2M $51.3M $67.5M $59.7M
Operating Income (Adjusted) -- $26.6M $51.2M $72.2M $66.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- $657.6M $2.4B $1.4B $816.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $451.7M $2.1B $1.1B $527.5M
Gross Profit -- $205.9M $220.8M $314.3M $289.4M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- $45.5M $57.5M $85M $94.8M
Other Inc / (Exp) -- -$5.5M -$35.3M $16.9M $23.7M
Operating Expenses -- $45.5M $57.5M $85M $94.8M
Operating Income -- $160.4M $163.4M $229.3M $194.6M
 
Net Interest Expenses -- $83.4M $65M $63.5M $63.1M
EBT. Incl. Unusual Items -- $71.5M $63.1M $182.7M $155.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $19.8M $18.8M $42.1M $28.2M
Net Income to Company -- -- $44.3M $140.7M $127M
 
Minority Interest in Earnings -- $4.3M -$29.6M -$107.4M -$101.3M
Net Income to Common Excl Extra Items -- $55.9M $14.7M $33.2M $25.7M
 
Basic EPS (Cont. Ops) -- $0.46 $0.26 $1.27 $1.01
Diluted EPS (Cont. Ops) -- $0.46 $0.26 $1.14 $0.99
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- $278.5M $257.1M $380.3M $323.8M
EBIT -- $154.9M $128.1M $246.2M $218.3M
 
Revenue (Reported) -- $657.6M $2.4B $1.4B $816.9M
Operating Income (Reported) -- $160.4M $163.4M $229.3M $194.6M
Operating Income (Adjusted) -- $154.9M $128.1M $246.2M $218.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- $549.8M $2B $918.9M $576.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $390.7M $1.8B $684.8M $351.4M
Gross Profit -- $159.1M $179.5M $234.1M $225.5M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- $34.1M $44.5M $63.4M $70.7M
Other Inc / (Exp) -- -$5.8M -$30.9M $11.7M $18.9M
Operating Expenses -- $34.1M $44.5M $63.4M $70.7M
Operating Income -- $125M $135M $170.7M $154.8M
 
Net Interest Expenses -- $62M $46.2M $50.1M $46.2M
EBT. Incl. Unusual Items -- $57.1M $57.9M $132.3M $127.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $14.1M $11.8M $25.5M $20.5M
Net Income to Company -- $43M $46.1M $106.8M $107M
 
Minority Interest in Earnings -- $3.2M -$26.4M -$80.1M -$85M
Net Income to Common Excl Extra Items -- $46.2M $19.7M $26.7M $22M
 
Basic EPS (Cont. Ops) -- $1.76 $0.26 $1.02 $0.87
Diluted EPS (Cont. Ops) -- $1.76 $0.26 $0.89 $0.85
Weighted Average Basic Share -- $66.8M $76.9M $78.8M $76.3M
Weighted Average Diluted Share -- $66.8M $76.9M $160.8M $77M
 
EBITDA -- $214.6M $200.2M $283.6M $251.3M
EBIT -- $119.1M $104.1M $182.4M $173.7M
 
Revenue (Reported) -- $549.8M $2B $918.9M $576.9M
Operating Income (Reported) -- $125M $135M $170.7M $154.8M
Operating Income (Adjusted) -- $119.1M $104.1M $182.4M $173.7M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $53.8M $90.2M $72.8M $516.7M $555.9M
Short Term Investments $8.8M $10.2M $12.2M $13.3M $16.5M
Accounts Receivable, Net $22M $24.5M $260.5M $79.7M $97.1M
Inventory $5.2M $22.4M $105M $173.6M $2.9M
Prepaid Expenses $4.6M $12.4M $16.2M $20.8M $10.3M
Other Current Assets -- -- -- -- --
Total Current Assets $99.6M $167.8M $490.4M $823.5M $699.6M
 
Property Plant And Equipment $1.6B $1.6B $1.5B $1.5B $1.7B
Long-Term Investments $450.8M $441.5M $435M $424.1M $404.8M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $22.9M $30.3M $35M $45M $56.9M
Total Assets $2.1B $2.3B $2.5B $2.9B $2.9B
 
Accounts Payable $6.2M $7.1M $311.6M $96.8M $13.8M
Accrued Expenses $36.3M $49.3M $67.5M $55.1M $76.2M
Current Portion Of Long-Term Debt $42.7M $33.9M $26.1M $28.6M $51M
Current Portion Of Capital Lease Obligations $49.4M $73.9M $67.7M $54.4M $23.8M
Other Current Liabilities $14.2M $15.7M $12.5M $3.7M $6.1M
Total Current Liabilities $158.6M $192.2M $520.2M $391.5M $203.8M
 
Long-Term Debt $626.3M $655.7M $405.6M $374.2M $505.1M
Capital Leases -- -- -- -- --
Total Liabilities $1.4B $1.5B $1.5B $1.2B $1.1B
 
Common Stock -- -- -- $108K $108K
Other Common Equity Adj -$9.5M -$15M -$9.2M $515K $505K
Common Equity $854.2M $887.1M $1.1B $477.4M $505.4M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -$108.9M -$116M -$115.9M $1.2B $1.3B
Total Equity $745.3M $771.2M $1B $1.7B $1.8B
 
Total Liabilities and Equity $2.1B $2.3B $2.5B $2.9B $2.9B
Cash and Short Terms $62.5M $100.5M $85M $530M $572.3M
Total Debt $668.9M $689.6M $431.7M $402.7M $556M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- $74.2M $345.7M $602.9M $608.4M
Short Term Investments -- $11.7M $12.8M $14.7M $42.6M
Accounts Receivable, Net -- $34.8M $317.4M $40M $75.5M
Inventory -- $6.8M $244.9M $18.2M $487K
Prepaid Expenses -- $13.5M $12.9M $13.9M $12.4M
Other Current Assets -- -- -- -- --
Total Current Assets -- $151.2M $956M $716.7M $764M
 
Property Plant And Equipment -- $1.5B $1.5B $1.7B $1.6B
Long-Term Investments -- $436.8M $424.7M $408M $407.6M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- $34.8M $47.2M $64.2M $72.2M
Total Assets -- $2.2B $3B $2.9B $2.9B
 
Accounts Payable -- $15.7M $368.1M $10.8M $8.6M
Accrued Expenses -- $43.4M $45.5M $58.1M $63.6M
Current Portion Of Long-Term Debt -- $34.9M $28.2M $48.9M $55.2M
Current Portion Of Capital Lease Obligations -- $69M $52.1M $25.7M $24.8M
Other Current Liabilities -- $14.6M $1.2M $3.7M $3.7M
Total Current Liabilities -- $189.5M $536.9M $172.6M $185.3M
 
Long-Term Debt -- $523.4M $392.1M $574.2M $463.7M
Capital Leases -- -- -- -- --
Total Liabilities -- $1.3B $1.3B $1.1B $981.7M
 
Common Stock -- -- $108K $108K $108K
Other Common Equity Adj -- -$11M $135K $2.1M -$381K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -$119.2M $1.1B $1.3B $1.4B
Total Equity -- $875M $1.6B $1.8B $1.9B
 
Total Liabilities and Equity -- $2.2B $3B $2.9B $2.9B
Cash and Short Terms -- $85.9M $358.4M $617.5M $651.1M
Total Debt -- $558.3M $420.3M $623.1M $518.9M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $48.3M $32.9M $41.2M $80M $126.8M
Depreciation & Amoritzation $102.7M $116.5M $128.4M $129M $129M
Stock-Based Compensation $950K -- -- -- --
Change in Accounts Receivable $4.3M -$2.5M -$247.2M $197.9M -$21M
Change in Inventories $35.1M -$17.1M -$82.7M -$68.6M $169.7M
Cash From Operations $153.2M $109M $141.6M $225.1M $231.9M
 
Capital Expenditures $47.5M $41.3M $36.1M $119.3M $312.7M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$47.5M -$41.3M -$36.1M -$119.3M -$308.6M
 
Dividends Paid (Ex Special Dividend) -$650K -$7.6M -- -$5.4M -$18.8M
Special Dividend Paid
Long-Term Debt Issued $117.9M $62.8M $118.3M $794M $250M
Long-Term Debt Repaid -$250.5M -$92.6M -$163.1M -$862.1M -$115.6M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $6.7M $6M -$79.4M $2.6M -$4.3M
Cash From Financing -$126.6M -$31.4M -$124.1M $341.2M $111.4M
 
Beginning Cash (CF) $94.1M $73.3M $109.5M $91M $538M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$20.8M $36.3M -$18.6M $447M $34.6M
Ending Cash (CF) $73.3M $109.5M $91M $538M $572.5M
 
Levered Free Cash Flow $105.7M $67.7M $105.5M $105.8M -$80.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- $1.4M $37.3M $46.5M $45.5M
Depreciation & Amoritzation -- $31.8M $32.6M $35.5M $23.5M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -$7.3M -$132.6M $99M -$35.7M
Change in Inventories -- $347K -$179.9M -- --
Cash From Operations -- $52.4M -$6.3M $170.8M $39.8M
 
Capital Expenditures -- $19.8M $21.8M $11.6M $11.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$19.8M -$21.8M -$11.6M -$11.4M
 
Dividends Paid (Ex Special Dividend) -- -$113K -$2.7M -$2.7M -$2.8M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $14M $3.4M -- --
Long-Term Debt Repaid -- -$21M -$13.6M -$16.6M -$18.8M
Repurchase of Common Stock -- -- -- -- -$6.9M
Other Financing Activities -- -$3.7M $2.3M $2.2M $535K
Cash From Financing -- -$10.9M -$10.5M -$17.2M -$27.9M
 
Beginning Cash (CF) -- $73.3M $405.7M $484.1M $626.1M
Foreign Exchange Rate Adjustment -- -- -- $62K -$48K
Additions / Reductions -- $21.8M -$38.7M $142M $391K
Ending Cash (CF) -- $95.1M $367M $626.2M $626.5M
 
Levered Free Cash Flow -- $32.7M -$28.1M $159.2M $28.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- $44.3M $140.7M $127M
Depreciation & Amoritzation -- -- $129M $134.1M $105.5M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -$293.1M $285.6M -$36.7M
Change in Inventories -- -- -$238M -- --
Cash From Operations -- -- -$4.7M $436.1M $231.4M
 
Capital Expenditures -- $30.8M $69.1M $359.8M $58M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -$69.1M -$355.7M -$58M
 
Dividends Paid (Ex Special Dividend) -- -$113K -$2.6M -$12.8M -$19.3M
Special Dividend Paid
Long-Term Debt Issued -- -- $871.6M -- --
Long-Term Debt Repaid -- -- -$948M -$54.5M -$127.1M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- $12.6M -$5M $708K
Cash From Financing -- -- $345.8M $178.8M -$173M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- $271.9M $259.2M $435K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -$73.9M $76.3M $173.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- $43M $46.1M $106.8M $107M
Depreciation & Amoritzation -- $95.4M $96.1M $101.1M $77.6M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -$10.3M -$56.2M $31.5M $15.8M
Change in Inventories -- $15.5M -$139.8M -- --
Cash From Operations -- $130.6M -$15.8M $195.3M $194.8M
 
Capital Expenditures -- $30.8M $63.9M $304.4M $49.7M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$30.8M -$63.9M -$300.3M -$49.7M
 
Dividends Paid (Ex Special Dividend) -- -$113K -$2.7M -$10.1M -$10.7M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $39.5M $792.8M $250M --
Long-Term Debt Repaid -- -$65M -$850M -$42.4M -$53.9M
Repurchase of Common Stock -- -- -- -- -$27.2M
Other Financing Activities -- -$88.5M $3.4M -$4.2M $759K
Cash From Financing -- -$114.1M $355.7M $193.3M -$91M
 
Beginning Cash (CF) -- $280.8M $599M $1.6B $1.8B
Foreign Exchange Rate Adjustment -- -- -- -$43K -$54K
Additions / Reductions -- -$14.4M $276.1M $88.3M $54.1M
Ending Cash (CF) -- $266.4M $875.1M $1.7B $1.8B
 
Levered Free Cash Flow -- $99.7M -$79.7M -$109.2M $145.1M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock